RxSight
RXST
RXST
173 hedge funds and large institutions have $481M invested in RxSight in 2025 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 74 increasing their positions, 39 reducing their positions, and 50 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
30% less first-time investments, than exits
New positions opened: 35 | Existing positions closed: 50
48% less capital invested
Capital invested by funds: $923M → $481M (-$442M)
88% less call options, than puts
Call options by funds: $455K | Put options by funds: $3.83M
Holders
173
Holding in Top 10
1
Calls
$455K
Puts
$3.83M
Top Buyers
| 1 | +$19.5M | |
| 2 | +$12M | |
| 3 | +$10.9M | |
| 4 |
NSGL
No Street GP LP
San Francisco,
California
|
+$9.02M |
| 5 |
Morgan Stanley
New York
|
+$8.95M |
Top Sellers
| 1 | -$30.7M | |
| 2 | -$13.2M | |
| 3 | -$10.8M | |
| 4 |
DDC
DF Dent & Co
Baltimore,
Maryland
|
-$10.6M |
| 5 |
DSCM
Divisadero Street Capital Management
Miami,
Florida
|
-$10M |